Announce Date | 02/26/2025 |
EPS Normalized Actual | $-1.18 (Beat by $0.2) |
EPS GAAP Actual | $-1.18 (Beat by $0.2) |
Revenue Actual | $1.99602B |
Revenue Surprise | Beat by $1996.02M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 0 | INF | 0 | 0 | 4 |
Dec 2028 | 7.22 | 4.41 | 7.10809 | 7.33548 | 8 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Oct 2024) | -0.42 | -0.42 | 2.14799B | -14.75% | 2147.99M |
FQ3 2024 (Jul 2024) | 0.75 | 0.75 | 2.68305B | -0.11% | 2683.05M |
FQ2 2024 (Apr 2024) | 0.67 | 0.67 | 3.40625B | 100% | 3406.25M |
FQ4 2023 (Dec 2023) | -0.59 | -0.59 | 2.46487B | -7.16% | 2464.87M |
FQ3 2023 (Jul 2023) | 1.44 | 1.44 | 2.68607B | 0.77% | 2686.07M |
FQ2 2023 (Apr 2023) | 0 | 0 | 0B | -INF% | 0M |
FQ4 2022 (Oct 2022) | 1.85 | 1.85 | 2.64134B | 100% | 2641.34M |
FQ3 2022 (Jul 2022) | 2.39 | 2.39 | 2.66543B | 100% | 2665.43M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Jan 2027) | 0.157 | -- | 0.14583 | 0.16566 | 4 |
FQ4 2026 (Oct 2026) | 1.11668 | -- | 1.08297 | 1.14604 | 1 |
FQ3 2026 (Jul 2026) | 0.063518 | -- | 0.06160067 | 0.06518817 | 1 |
FQ2 2026 (Apr 2026) | 0.83621 | -- | 0.81097 | 0.8582 | 1 |
FQ1 2026 (Mar 2026) | -0.13973 | -- | -0.14713 | -0.13582 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Jan 2027) | 1.88B | -- | 1.78B | 1.96B | 7 |
FQ4 2026 (Oct 2026) | 2.57B | -- | 2.51B | 2.62B | 2 |
FQ3 2026 (Jul 2026) | 2.17B | -- | 2.12B | 2.21B | 2 |
FQ2 2026 (Apr 2026) | 2.36B | -- | 2.3B | 2.41B | 2 |
FQ1 2026 (Mar 2026) | 2.56B | -- | 2.51B | 2.67B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Oct 2024) | -0.42 | -0.42 | 100% | |
FQ3 2024 (Jul 2024) | 0.75 | 0.75 | 100% | |
FQ2 2024 (Apr 2024) | 0.67 | 0.67 | 100% | |
FQ4 2023 (Dec 2023) | -0.59 | -0.59 | 100% | |
FQ3 2023 (Jul 2023) | 1.44 | 1.44 | 100% | |
FQ2 2023 (Apr 2023) | 0 | 0 | NAN% | |
FQ4 2022 (Oct 2022) | 1.85 | 1.85 | 100% | |
FQ3 2022 (Jul 2022) | 2.39 | 2.39 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Oct 2024) | $0B | $2.15B | $2147.99M | 100% |
FQ3 2024 (Jul 2024) | $0B | $2.68B | $2683.05M | 100% |
FQ2 2024 (Apr 2024) | $0B | $3.41B | $3406.25M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.46B | $2464.87M | 100% |
FQ3 2023 (Jul 2023) | $0B | $2.69B | $2686.07M | 100% |
FQ2 2023 (Apr 2023) | $0B | $0B | $0M | NAN% |
FQ4 2022 (Oct 2022) | $0B | $2.64B | $2641.34M | 100% |
FQ3 2022 (Jul 2022) | $0B | $2.67B | $2665.43M | 100% |